CAR-T（CAR-T）细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
评估商业保险患者接受 CAR-T 细胞治疗后的住院和急诊就诊情况
英文原题：Assessment of Hospitalizations and Emergency Department Visits After Chimeric Antigen Receptor T-Cell Therapy Among Commercially Insured Patients.
查看英文原题
Assessment of Hospitalizations and Emergency Department Visits After Chimeric Antigen Receptor T-Cell Therapy Among Commercially Insured Patients.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
中文摘要
本队列研究考察了商业保险患者在接受CAR-T 细胞输注住院后最初12个月内的再住院和急诊就诊累积发生率。
展开英文摘要原文
This cohort study examines the cumulative incidence of rehospitalizations and emergency department visits during the first 12 months after hospitalization for chimeric antigen receptor T-cell infusion among commercially insured patients.
论文信息
- 作者
- Kenzik KM、Johnson PC、Bhatia R、Bhatia S
- 单位
- Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham.United States
- 文献类型
- 非美国政府资助研究
- 期刊
- JAMA oncology2022 Jul 1
- 原文标识
- PubMed 35511173 · DOI 10.1001/jamaoncol.2022.1044
在 PubMed 查看 → 出版商原文（DOI） 全文 PDF（PMC）· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →